Intrinsic Value of S&P & Nasdaq Contact Us

Alvotech ALVOW NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • IS • USD

SharesGrow Score
57/100
2/6 Pass
SharesGrow Intrinsic Value
$76.24
+29223.1%

Alvotech (ALVOW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Analysts estimate Earnings Per Share (EPS) of $-0.13 and revenue of $0.45B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.87 vs est $-0.13 (missed -593.3%). 2025: actual $0.10 vs est $-0.08 (beat +223.1%). Analyst accuracy: 0%.

EPS Estimates — ALVOW

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.87 vs Est –$0.13 ▼ 85.6% off
2025 Actual $0.10 vs Est –$0.08 ▲ 181.2% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.

Revenue Estimates — ALVOW

96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.490B vs Est $0.454B ▲ 7.2% off
2025 Actual $0.586B vs Est $0.581B ▲ 0.9% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message